New Annual Reporting for U.S. FDA Drug Listings
The U.S. Food and Drug Administration (FDA) requires registered Drug Establishments to annually report the distributed quantities for each of their listed drug products. The suggested deadline for reporting drug quantities distributed during calendar year 2022 is February 15, 2023.
Registrar Corp can help file these reports on your behalf as part of our U.S. Agent and Registrant Contact service (Note: Additional fees may apply for migration of listings not currently managed by Registrar Corp). For assistance, simply complete the form below.
